Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2018-2021, April 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imamura, F.
Right arrow Articles by Akedo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imamura, F.
Right arrow Articles by Akedo, H.

Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Adriamycin1

Fumio Imamura2, Takeshi Horai, Mutsuko Mukai, Kiyoko Shinkai and Hitoshi Akedo

Department of Internal Medicine [F. I.], Clinical Research for Lung Cancer [T. H.], and Department of Tumor Biochemistry [M. M., K. S., H. A.], Research Institute, The Center for Adult Diseases, Osaka, Osaka 537, Japan

The effect of Adriamycin on the invasive capacity of rat ascites hepatoma cells, W1, was studied. The invasive capacity of W1 cells was estimated in vitro by counting the number of penetrated single tumor cells and tumor cell colonies formed from the penetrated cells underneath a cultured mesothelial cell monolayer (H. Akedo et al., Cancer Res., 46: 2416–2422, 1986). A considerable increment of the invasive capacity was observed when the tumor cells had been treated with 1.0 to 20.0 µM Adriamycin. This augmentation of invasive capacity of tumor cells was partially inhibited by 60 µM N-acetylcysteine, a scavenger of free radicals. On the other hand, 60 µM N-acetylcysteine did not impair the cytotoxicity of Adriamycin for W1 cells measured by an in vitro tetrazolium-based colorimetric assay for cytotoxicity.

1 This work was supported in part by a Grant-in-Aid from the Ministry of Health and Welfare for a Comprehensive 10-Year Strategy of Cancer Control and a grant from Osaka Association for the Prevention of Adult Diseases.

2 To whom requests for reprints should be addressed.

Received 8/22/89. Revised 12/ 4/89.


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yang, R. Rao, J. Shen, Y. Tang, W. Fiskus, J. Nechtman, P. Atadja, and K. Bhalla
Role of Acetylation and Extracellular Location of Heat Shock Protein 90{alpha} in Tumor Cell Invasion
Cancer Res., June 15, 2008; 68(12): 4833 - 4842.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. Gdynia, K. Grund, A. Eckert, B. C. Bock, B. Funke, S. Macher-Goeppinger, S. Sieber, C. Herold-Mende, B. Wiestler, O. D. Wiestler, et al.
Basal Caspase Activity Promotes Migration and Invasiveness in Glioblastoma Cells
Mol. Cancer Res., December 1, 2007; 5(12): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Mukai, T. Kusama, Y. Hamanaka, T. Koga, H. Endo, M. Tatsuta, and M. Inoue
Cross Talk between Apoptosis and Invasion Signaling in Cancer Cells through Caspase-3 Activation
Cancer Res., October 15, 2005; 65(20): 9121 - 9125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.